| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 08/16/2007 | US20070191401 Transplant rejection, autoimmune disease, autoimmune disease |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/14/2007 | US7256190 Thiazole compounds useful as inhibitors of protein kinase |
| 08/09/2007 | WO2007087684A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 08/09/2007 | US20070184061 Indolylmaleimide derivatives |
| 08/09/2007 | CA2640678A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 08/08/2007 | EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/08/2007 | CN1330633C Pyrrolidine derivatives as oxytocin antagonists |
| 08/08/2007 | CN101012193A Novel CB 1 receptour inverse agonists |
| 08/07/2007 | US7253289 reacting formaldehyde with alkylamine; acidification in water, glyooxal solution; separation |
| 08/07/2007 | US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes |
| 08/07/2007 | US7252791 sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers |
| 08/07/2007 | CA2302943C Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7250443 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 07/31/2007 | CA2275306C Novel tetrahydrobenzindolone derivatives |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/24/2007 | US7247740 Reacting perfluoroalkanesulfonic acid directly with dialkyl carbonate to give alkyl perfluoroalkanesulfonate optionally in the presence of a water or alcohol consuming reagent, and preparing an alkyl perfluoroalkanesulfonate with an alkylamine or alkylphosphine to prepare perfluoroalkanesulfonic acid |
| 07/24/2007 | US7247635 Pyrazole derivative |
| 07/18/2007 | EP1807435A1 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 07/18/2007 | CN1326850C Tricyclic farnesyl protein transferase inhibitors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/11/2007 | EP1651614B1 Method for the production of purified 1,3-substituted imidazolium salts |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/10/2007 | US7241780 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/05/2007 | US20070155919 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins |
| 07/05/2007 | US20070155817 Indolylmaleimide derivatives |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/04/2007 | EP0977750B1 Farnesyltransferase inhibiting quinazolinones |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235656 Anxiolytic agents with reduced sedative and ataxic effects |
| 06/26/2007 | US7235584 Dibenzo[b,d]pyran derivatives as neuroprotectant, antiinflammatory, and antiischemic agents; brain, cardiovascular, neurodegenerative, autoimmune and nervous system disorders; Grave*s, Hashimoto*s, Alzheimer*s, Parkinson*s, and Huntington*s disease; amyotrophic lateral sclerosis; drug abuse, alcoholism |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/21/2007 | US20070142646 Method of preparing ionic liquids |
| 06/21/2007 | US20070142391 Piperazine-2-carboxamide derivatives |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/19/2007 | US7232912 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/14/2007 | US20070135432 Mitotic kinesin KSP inhibitors; antiproliferative agents; 2-methylpyrimidin-4-ones |
| 06/13/2007 | EP1499623B1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one |
| 06/13/2007 | CN1321112C Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/12/2007 | US7230023 Triazole compound containing a phosphonate group |
| 06/12/2007 | US7229986 Melanin-concentrating hormone antagonist |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/06/2007 | CN1319952C Method for preparing oxazolidone amine |
| 05/31/2007 | US20070123711 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole) |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/29/2007 | US7223757 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 05/24/2007 | US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 05/24/2007 | US20070117787 N-[(3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]piperidine-4-acetic acid; in combination with a statin, lowering cholesterol-level and lowering triglyceride-level |
| 05/23/2007 | CN1966505A Imidazole [1,2-alpha] purine derivative, method of producing same and use thereof |
| 05/22/2007 | US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 05/22/2007 | CA2157146C Heterocyclyl-benzoylguanidines |
| 05/16/2007 | CN1962417A Stabilized hydroxylamine solutions |
| 05/16/2007 | CN1315824C R- - -1- [2- 7-chlorobenzo [b] thiophen-3 -yl- methoxy -2- 2,4-dichlorophenyl -ethyl] -1h-imidazole |
| 05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/09/2007 | EP1313712B1 Process and intermediates for preparing retroviral protease inhibitors |
| 05/08/2007 | US7214694 Controlling transforming growth facor; artificial skin; wound healing agents |
| 05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
| 05/08/2007 | US7214506 Method for treating onychomycosis |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070095645 Setting a pressure not higher than ambient pressure andheating to a temperature of 60-350 degrees C., wherein cations, anions and uncharged molecules are present in equilibrium in the ionic liquid; purification; circulation; ionic solvents |
| 05/02/2007 | EP0869968B1 Growth-hormone secretagogues |
| 04/26/2007 | DE102006050717A1 Preparation of functionalized five-membered ring heterocycles, useful in preparation of pharmaceuticals and plant-protection agents, by reaction with electrophile, hydrogen acceptor and alkali metal |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | EP1024138B1 Pyrazole derivatives |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/19/2007 | US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects; |
| 04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 04/18/2007 | EP1186296B1 Mag expression promoters |
| 04/18/2007 | EP1028940B1 Process to produce oxazolidinones |
| 04/18/2007 | CN1950367A 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors |
| 04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | CA2226214C Antifungal agent, compound therefor, process for producing the same, and method for using the same |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082375 Topically administering to a nail of subject having onychomycosis a therapeutically effective amount of an antifungal compound such as (2R, 3R)-2-(2,4-difluorophenyl)-3-(4-methylen piperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol |
| 04/11/2007 | EP1772453A1 Process to produce Oxazolidinones |